|
1
|
Kim A, Ueda Y, Naka T and Enomoto T:
Therapeutic strategies in epithelial ovarian cancer. J Exp Clin
Cancer Res. 31:142012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siddik ZH: Cisplatin: mode of cytotoxic
action and molecular basis of resistance. Oncogene. 22:7265–7279.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Galluzzi L, Senovilla L, Vitale I, et al:
Molecular mechanisms of cisplatin resistance. Oncogene.
31:1869–1883. 2012. View Article : Google Scholar
|
|
4
|
Carew JS, Nawrocki ST and Cleveland JL:
Modulating autophagy for therapeutic benefit. Autophagy. 3:464–467.
2007. View Article : Google Scholar
|
|
5
|
Mathew R, Karantza-Wadsworth V and White
E: Role of autophagy in cancer. Nat Rev Cancer. 7:961–967. 2007.
View Article : Google Scholar
|
|
6
|
Eskelinen EL and Saftig P: Autophagy: a
lysosomal degradation pathway with a central role in health and
disease. Biochim Biophys Acta. 1793:664–673. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mizushima N, Levine B, Cuervo AM and
Klionsky DJ: Autophagy fights disease through cellular
self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guo XL, Li D, Hu F, et al: Targeting
autophagy potentiates chemotherapy-induced apoptosis and
proliferation inhibition in hepatocarcinoma cells. Cancer Lett.
320:171–179. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
O’Donovan TR, O’Sullivan GC and McKenna
SL: Induction of autophagy by drug-resistant esophageal cancer
cells promotes their survival and recovery following treatment with
chemotherapeutics. Autophagy. 7:509–524. 2011.PubMed/NCBI
|
|
10
|
Wu MY, Fu J, Xu J, O’Malley BW and Wu RC:
Steroid receptor coactivator 3 regulates autophagy in breast cancer
cells through macrophage migration inhibitory factor. Cell Res.
22:1003–1021. 2012. View Article : Google Scholar
|
|
11
|
Sirichanchuen B, Pengsuparp T and
Chanvorachote P: Long-term cisplatin exposure impairs autophagy and
causes cisplatin resistance in human lung cancer cells. Mol Cell
Biochem. 364:11–18. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bao LJ, Jaramillo MC, Zhang ZB, et al:
Nrf2 induces cisplatin resistance through activation of autophagy
in ovarian carcinoma. Int J Clin Exp Pathol. 7:1502–1513.
2014.PubMed/NCBI
|
|
13
|
Wang CY, Cusack JC Jr, Liu R and Baldwin
AS Jr: Control of inducible chemoresistance: enhanced anti-tumor
therapy through increased apoptosis by inhibition of NF-kappaB. Nat
Med. 5:412–417. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gallego MA, Joseph B, Hemström TH, et al:
Apoptosis-inducing factor determines the chemoresistance of
non-small-cell lung carcinomas. Oncogene. 23:6282–6291. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu H, Su J, Xu Y, et al: p62/SQSTM1
involved in cisplatin resistance in human ovarian cancer cells by
clearing ubiquitinated proteins. Eur J Cancer. 47:1585–1594. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kihara A, Kabeya Y, Ohsumi Y and Yoshimori
T: Beclin-phosphatidylinositol 3-kinase complex functions at the
trans-Golgi network. EMBO Rep. 2:330–335. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kabeya Y, Mizushima N, Ueno T, et al: LC3,
a mammalian homologue of yeast Apg8p, is localized in autophagosome
membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pankiv S, Clausen TH, Lamark T, Brech A,
Bruun JA, Outzen H, Øvervatn A, Bjørkøy G and Johansen T:
p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of
ubiquitinated protein aggregates by autophagy. J Biol Chem.
282:24131–24145. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mathew R, Karp CM, Beaudoin B, et al:
Autophagy suppresses tumorigenesis through elimination of p62.
Cell. 137:1062–1075. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Seglen PO and Gordon PB: 3-Methyladenine:
specific inhibitor of autophagic/lysosomal protein degradation in
isolated rat hepatocytes. Proc Natl Acad Sci USA. 79:1889–1892.
1982. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stroikin Y, Dalen H, Lööf S and Terman A:
Inhibition of autophagy with 3-methyladenine results in impaired
turnover of lysosomes and accumulation of lipofuscin-like material.
Eur J Cell Biol. 83:583–590. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu D, Yang Y, Liu Q and Wang J:
Inhibition of autophagy by 3-MA potentiates cisplatin-induced
apoptosis in esophageal squamous cell carcinoma cells. Med Oncol.
28:105–111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zou Z, Wu L, Ding H, et al: MicroRNA-30a
sensitizes tumor cells to cis-platinum via suppressing Beclin
1-mediated autophagy. J Biol Chem. 287:4148–4156. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li J, Hou N, Faried A, Tsutsumi S,
Takeuchi T and Kuwano H: Inhibition of autophagy by 3-MA enhances
the effect of 5-FU-induced apoptosis in colon cancer cells. Ann
Surg Oncol. 16:761–771. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu Y, Zhao L, Liu L, et al: Beclin 1
cleavage by caspase-3 inactivates autophagy and promotes apoptosis.
Protein Cell. 1:468–477. 2010. View Article : Google Scholar : PubMed/NCBI
|
